ERBB2 and breast carcinoma: The her2st (Andersson et al. 2021) and stnet (He et al. 2020) datasets include 13 620 and 30 655 Visium spots, respectively, from HER2-positive breast cancer and general breast cancer tissues, each paired with H&E and gene expression data.